PPT Slide
Discuss options with FDA to move program forward, including a Phase III protocol that leverages existing safety data
Initiate an oral heparin trial in Q2 2005
Design protocol that meets regulatory requirement for approval
- Minimize patient inconvenience
- Maximize speed to market
Near Term Oral Heparin Plan